{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:15:35Z","timestamp":1770290135780,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81473283"],"award-info":[{"award-number":["81473283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81320108027"],"award-info":[{"award-number":["81320108027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81173131"],"award-info":[{"award-number":["81173131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Ministry of China","award":["2012ZX09506001-004"],"award-info":[{"award-number":["2012ZX09506001-004"]}]},{"name":"Major Scientific and Technological Project of Guangdong Province","award":["2011A080300001"],"award-info":[{"award-number":["2011A080300001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.dmpk.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T21:11:36Z","timestamp":1521234696000},"page":"165-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy"],"prefix":"10.1016","volume":"34","author":[{"given":"Juan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qibiao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuojia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liemin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.dmpk.2018.01.006_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"issue":"18","key":"10.1016\/j.dmpk.2018.01.006_bib2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2217\/pgs-2016-0093","article-title":"Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese","volume":"17","author":"Li","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"10","key":"10.1016\/j.dmpk.2018.01.006_bib3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/jnnp.2004.045690","article-title":"The natural history of epilepsy: an epidemiological view","volume":"75","author":"Kwan","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.dmpk.2018.01.006_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","article-title":"The consequences of refractory epilepsy and its treatment","volume":"37","author":"Laxer","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"5304","key":"10.1016\/j.dmpk.2018.01.006_bib5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.275.5304.1327","article-title":"Genetic analysis of complex disease","volume":"275","author":"Bell","year":"1997","journal-title":"Science (New York, NY)"},{"issue":"8","key":"10.1016\/j.dmpk.2018.01.006_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"Loscher","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"10.1016\/j.dmpk.2018.01.006_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dmpk.2018.01.006_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60327-411-1_1","article-title":"SNPs: impact on gene function and phenotype","volume":"578","author":"Shastry","year":"2009","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00210-003-0813-5","article-title":"Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution","volume":"369","author":"Gerloff","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2133\/dmpk.DMPK-12-RV-099","article-title":"Impact of genetic variation in OATP transporters to drug disposition and response","volume":"28","author":"Gong","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.dmpk.2018.01.006_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/138945011795378487","article-title":"Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition","volume":"12","author":"Haufroid","year":"2011","journal-title":"Curr Drug Targets"},{"issue":"15","key":"10.1016\/j.dmpk.2018.01.006_bib12","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 gene expression in brain of patients with medically intractable epilepsy","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.dmpk.2018.01.006_bib14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/01.WNL.0000137051.33486.C7","article-title":"Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy","volume":"63","author":"Tan","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.dmpk.2018.01.006_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.31887\/DCNS.2006.8.3\/fgirardin","article-title":"Membrane transporter proteins: a challenge for CNS drug development","volume":"8","author":"Girardin","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"issue":"10","key":"10.1016\/j.dmpk.2018.01.006_bib16","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2174\/13816128113199990462","article-title":"Role of monocarboxylate transporters in drug delivery to the brain","volume":"20","author":"Vijay","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1602\/neurorx.2.1.73","article-title":"Active efflux across the blood-brain barrier: role of the solute carrier family","volume":"2","author":"Kusuhara","year":"2005","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.dmpk.2018.01.006_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5808\/GI.2013.11.4.254","article-title":"Genetic variations of ABCC2 gene associated with adverse drug reactions to valproic acid in Korean epileptic patients","volume":"11","author":"Yi","year":"2013","journal-title":"Genomics Inform"},{"issue":"3","key":"10.1016\/j.dmpk.2018.01.006_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2217\/pgs.10.183","article-title":"Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy","volume":"12","author":"Kwan","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.dmpk.2018.01.006_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0166-0934(91)90126-K","article-title":"An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents","volume":"34","author":"Loparev","year":"1991","journal-title":"J\u00a0Virol Meth"},{"issue":"2","key":"10.1016\/j.dmpk.2018.01.006_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","article-title":"SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res"},{"issue":"11","key":"10.1016\/j.dmpk.2018.01.006_bib23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FPC.0b013e32833f2cd0","article-title":"Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype","volume":"20","author":"Moncrieffe","year":"2010","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2011.08.001","article-title":"Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy","volume":"45","author":"Lauritzen","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.dmpk.2018.01.006_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nbd.2010.11.005","article-title":"Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus","volume":"41","author":"Lauritzen","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.dmpk.2018.01.006_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/glia.22344","article-title":"Redistribution of monocarboxylate transporter 2 on the surface of astrocytes in the human epileptogenic hippocampus","volume":"60","author":"Lauritzen","year":"2012","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.dmpk.2018.01.006_bib27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00432-014-1877-y","article-title":"Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer","volume":"141","author":"Fei","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"7","key":"10.1016\/j.dmpk.2018.01.006_bib28","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","article-title":"Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB\/IL-8 pathway that drives tumor angiogenesis","volume":"71","author":"Vegran","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/bbrc.2000.2922","article-title":"Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family","volume":"273","author":"Tamai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.dmpk.2018.01.006_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.taap.2004.08.012","article-title":"Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin","volume":"203","author":"Fischer","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.dmpk.2018.01.006_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/jpet.302.2.804","article-title":"Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis","volume":"302","author":"Nozawa","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.dmpk.2018.01.006_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FPC.0b013e32834300cc","article-title":"The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans","volume":"21","author":"Imanaga","year":"2011","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"10.1016\/j.dmpk.2018.01.006_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/17425255.2.3.351","article-title":"Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition","volume":"2","author":"Jedlitschky","year":"2006","journal-title":"Expert Opin Drug Metabol Toxicol"},{"issue":"3","key":"10.1016\/j.dmpk.2018.01.006_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eplepsyres.2005.11.011","article-title":"Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis","volume":"68","author":"Kubota","year":"2006","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eplepsyres.2003.12.008","article-title":"Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport","volume":"58","author":"Gibbs","year":"2004","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.dmpk.2018.01.006_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/epi.12132","article-title":"A\u00a0systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy","volume":"54","author":"Grover","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.dmpk.2018.01.006_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.fpc.0000197467.21964.67","article-title":"Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance","volume":"16","author":"Leschziner","year":"2006","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"10.1016\/j.dmpk.2018.01.006_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1211\/jpp.60.5.0009","article-title":"ABCC2 haplotype is not associated with drug-resistant epilepsy","volume":"60","author":"Seo","year":"2008","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.dmpk.2018.01.006_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1755-5949.2012.00336.x","article-title":"ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients","volume":"18","author":"Qu","year":"2012","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"10.1016\/j.dmpk.2018.01.006_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/pgs.13.239","article-title":"ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts","volume":"15","author":"Sha'ari","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.dmpk.2018.01.006_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/FPC.0b013e328338073a","article-title":"A\u00a0nonsynonymous variation in MRP2\/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy","volume":"20","author":"Kim","year":"2010","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"10.1016\/j.dmpk.2018.01.006_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/FPC.0b013e3283528217","article-title":"Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs","volume":"22","author":"Grover","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.106.102491","article-title":"Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in\u00a0vitro and in\u00a0vivo transport assays","volume":"320","author":"Baltes","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.dmpk.2018.01.006_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","article-title":"Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain","volume":"129","author":"Nies","year":"2004","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.dmpk.2018.01.006_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.qai.0000225013.53568.69","article-title":"Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study","volume":"42","author":"Anderson","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr (1999)"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib46","doi-asserted-by":"crossref","first-page":"e0147724","DOI":"10.1371\/journal.pone.0147724","article-title":"A\u00a0single-nucleotide polymorphism in ABCC4 is associated with tenofovir-related Beta2-Microglobulinuria in Thai patients with HIV-1 infection","volume":"11","author":"Likanonsakul","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.dmpk.2018.01.006_bib47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1590\/SO100-720320150005292","article-title":"Gene expression profile of ABC transporters and cytotoxic effect of ibuprofen and acetaminophen in an epithelial ovarian cancer cell line in\u00a0vitro","volume":"37","author":"Lima","year":"2015","journal-title":"Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia"},{"issue":"7","key":"10.1016\/j.dmpk.2018.01.006_bib48","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2008-11-191098","article-title":"Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia","volume":"114","author":"Ansari","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.dmpk.2018.01.006_bib49","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/508546","article-title":"Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy","volume":"194","author":"Izzedine","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.dmpk.2018.01.006_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1124\/jpet.108.136523","article-title":"The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene","volume":"325","author":"Abla","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.dmpk.2018.01.006_bib51","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/FPC.0b013e3283307cba","article-title":"Pharmacogenetic association study of 30 genes with phenobarbital drug response in epileptic dogs","volume":"19","author":"Kennerly","year":"2009","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"10.1016\/j.dmpk.2018.01.006_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","article-title":"Interaction between valproic acid and carbapenem antibiotics","volume":"39","author":"Mori","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmpk.2018.01.006_bib53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-015-0275-x","article-title":"New trends for overcoming ABCG2\/BCRP-mediated resistance to cancer therapies","volume":"34","author":"Westover","year":"2015","journal-title":"J\u00a0Exp Clin Cancer Res: CR"},{"issue":"10","key":"10.1016\/j.dmpk.2018.01.006_bib54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.numecd.2014.05.009","article-title":"Resistance and intolerance to statins","volume":"24","author":"Reiner","year":"2014","journal-title":"Nutr Metabol Cardiovasc Dis: NMCD"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmpk.2018.01.006_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2015.01.015","article-title":"The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2)","volume":"93","author":"Romermann","year":"2015","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.dmpk.2018.01.006_bib57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1528-1167.2006.00453.x","article-title":"Lack of interactions between breast cancer resistance protein (bcrp\/abcg2) and selected antiepileptic agents","volume":"47","author":"Cerveny","year":"2006","journal-title":"Epilepsia"},{"issue":"1\u20133","key":"10.1016\/j.dmpk.2018.01.006_bib58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2013.03.049","article-title":"Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models","volume":"710","author":"Nakanishi","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.dmpk.2018.01.006_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/cncr.22760","article-title":"Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer","volume":"110","author":"Han","year":"2007","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.dmpk.2018.01.006_bib60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3899\/jrheum.130870","article-title":"Joint effects of alcohol consumption and ABCG2 Q141K on chronic tophaceous gout risk","volume":"41","author":"Tu","year":"2014","journal-title":"J\u00a0Rheumatol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436716305675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436716305675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:54:30Z","timestamp":1761162870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436716305675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1347436716305675"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.01.006","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}